Ischemic Stroke Clinical Trial
— TOOLSOfficial title:
Adapting Tools to Implement Stroke Risk Management to Veterans
Verified date | September 2018 |
Source | VA Office of Research and Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to develop and evaluate the local adaptation of existing stroke
prevention tools into practice. A stroke prevention program is a collection of materials
including written materials like pamphlets and brochures, videotapes and training guides for
stroke survivors and evidence based guidelines for the doctors that provide care for them.
Other tools that may be used in a stroke prevention program include devices that help
patients monitor medical symptoms at home like home blood pressure machines or blood sugar
monitors and messaging devices that allow reporting symptoms from home to a health care
provider.
We hypothesized Veterans with stroke who receive the Veteran Stroke Prevention Program would
engage in better medication compliance and stroke specific quality of life compared to those
who did not receive the program.
Status | Completed |
Enrollment | 174 |
Est. completion date | December 2013 |
Est. primary completion date | June 2011 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Veterans 18 years or older hospitalized with stroke or Transient Ischemic Attack at Indianapolis Veterans Administration Medical Center and Houston Veteran Administration Medical Center; - willing to participate; - access to telephone; - speaks and understands English; - no severe cognitive impairments; - life expectancy of at least 6 mos; - willingness to follow-up in Veterans Administration outpatient care. Exclusion Criteria: - Severe aphasia or cognitive impairment; - active alcohol or substance abuse; - cannot or unwilling to participate; - does not speak or understand English; - life expectancy less than 6 mos; - no access to telephone; - no Veterans Administration outpatient follow-up. |
Country | Name | City | State |
---|---|---|---|
United States | Michael E. DeBakey VA Medical Center, Houston, TX | Houston | Texas |
United States | Richard L. Roudebush VA Medical Center, Indianapolis, IN | Indianapolis | Indiana |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development | Indiana University |
United States,
Damush TM, Jackson GL, Powers BJ, Bosworth HB, Cheng E, Anderson J, Guihan M, LaVela S, Rajan S, Plue L. Implementing evidence-based patient self-management programs in the Veterans Health Administration: perspectives on delivery system design considerati — View Citation
Schmid AA, Andersen J, Kent T, Williams LS, Damush TM. Using intervention mapping to develop and adapt a secondary stroke prevention program in Veterans Health Administration medical centers. Implement Sci. 2010 Dec 15;5:97. doi: 10.1186/1748-5908-5-97. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Stroke Specific Health Related Quality of Life | Stroke Specifc, Health Related Quality of Life (SSQoL) Self reported survey by LS Williams Weinberger M, Clark, D, Harris L, Biller J. Development of a stroke specific quality of life scale. Stroke, 1999;30:1362-1369. Contains 12 domains and 49 items Scored on a 5 pt Likert response format with lower score indicating worse function/lower ability on that item or domain. Domain scores were calculated as an unweighted average of item scores in that domain. Overall Total Score was calculated as an unweighted average of domain scores. We hypothesized the intervention group would report significantly greater stroke specific quality of life than the control group. The level of significance was set to 0.05. |
6 months for (SSQoL) and 3 months for Perceived Energy Subdomain | |
Primary | Self-Efficacy to Manage Stroke Symptoms | Confidence to manage symptoms and health post stroke on a 1-10 scale where 10 denotes a lot of confidence and a 1 denotes no confidence. | 6 months | |
Secondary | Medication (Diabetes) Compliance for Secondary Stroke Prevention Risk Factor Managment | Medication Possession Ratios 6 months post stroke events based upon Pharmacy Refill data Medication Possession Ratios are the % of days in follow up period of 6 months with possession of oral Diabetes drugs (range = 0 -100%) Compliance is defined as Medication Possession Ratio for Diabetes drugs dichotomized as greater than and equal to 80% |
baseline, 6 months | |
Secondary | Medication (Statins) for Secondary Stroke Prevention Risk Factor Management | Medication Possession Ratios 6 months post stroke event based upon Pharmacy Refill data Medication Possession Ratios are the % of days in follow up period of 6 months with possession of Statin drugs (range= 0-100%). Compliance is defined as Medication Possession Ratio for Statin drugs dichotomized as greater than and equal to 80%. |
baseline, 6 months | |
Secondary | Medication (Hypertension) Compliance for Secondary Stroke Prevention Risk Factor Management | Medication Possession Ratios 6 months post stroke event based upon Pharmacy Refill data Medication Possession Ratios are the % of days in follow up period of 6 months with possession of hypertension drugs (range = 0-100%) Compliance is defined as Medication Possession Ratio for Hypertension drugs dichotomized as greater than and equal to 80%. |
Baseline, 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A | |
Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 |